Related Experiment Videos
Recent advances in research on Parkinsonism
Acta Neurologica Scandinavica. Supplementum
|January 1, 1978
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging.
Synapse (New York, N.Y.)·2001
Impairment of semantic knowledge in Parkinson disease.
Archives of neurology·2000
The quality of life in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society·2000
Environmental risk factors in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society·1999
Sleep quality and arousal in migraine and tension-type headache: the headache-sleep study.
Acta neurologica Scandinavica. Supplementum·2014
Diffusion-weighted lesions in acute ischaemic stroke patients with migraine.
Acta neurologica Scandinavica. Supplementum·2014
Mild stroke: safety and outcome in patients receiving thrombolysis.
Acta neurologica Scandinavica. Supplementum·2014
MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.
Acta neurologica Scandinavica. Supplementum·2014
Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries.
Acta neurologica Scandinavica. Supplementum·2014
Advances in genetic diagnosis of neurological disorders.
Acta neurologica Scandinavica. Supplementum·2014
Gastrointestinal In Situ Self-Assembled Gastrodia Elata Polysaccharide Hydrogel Enables Parkinson's Disease Therapy via Gut-Brain Axis Modulation.
Small (Weinheim an der Bergstrasse, Germany)·2026
Efficacy and Cardiovascular Safety of Pegmolesatide in Patients with Anemia of Chronic Kidney Disease: Post hoc Analysis of Two Phase 3 Randomized Trials.
Kidney diseases (Basel, Switzerland)·2026
Sustained-release local anesthetics: advances in drug delivery systems for prolonged postoperative analgesia.
Anesthesia and pain medicine·2026
Evaluating Zasocitinib as an oral therapy for moderate to severe plaque Psoriasis.
Expert opinion on pharmacotherapy·2026